一个分层的短微针缩双放大贴片能够加速,统一,无痛地通过皮肤递送细胞外囊泡
Minwoo Song1, Minji Ha1, Sol Shin1
1School of Chemical Engineering, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, 16419, Republic of Korea.
Nano-micro letters
|July 23, 2025
概括
这项研究引入了一种新型的微针贴片 (MN@EV/SC),配有吸管,用于增强细胞外囊泡 (EV) 通过皮肤传递. 该设计尽量减少疼痛和刺激,同时改善EV透以再生皮肤.
科学领域:
- 生物材料科学 生物材料科学
- 皮肤药物输送 皮肤药物输送
- 再生医学是一种再生医学.
背景情况:
- 微针 (MNs) 正在探索通过皮肤传递像细胞外囊泡 (EVs) 这样的大分子.
- 传统的长MNs (≥600μm) 引起疼痛和皮肤刺激,限制了它们的应用.
- 在不均的皮肤上稳定的MN应用对于统一的纳米尺度药物递送至关重要.
研究的目的:
- 开发一种双增强的皮肤贴片 (MN@EV/SC),以有效地提供源自干细胞的EV.
- 整合一个以章鱼为灵感的吸管 (SC) 与短的MN (≤300微米) 进行改进的皮肤透和粘附.
- 评估MN@EV/SC系统在增强EV传递和促进皮肤再生方面的有效性.
主要方法:
- 开发了MN@EV/SC贴片,结合了短的MN和吸管.
- 在鼠标模型中对MN透深度和皮肤应激反应的体内评估.
- 评估EV透和随后对纤维细胞复兴和原蛋白合成的影响.
主要成果:
- 与单独的MN (111微米) 相比,MN@EV/SC补丁实现了显著更深的EV透 (290微米).
- 短的MN引起了与化学粘合剂相比较的应激反应,与长的MN不同.
- 该贴片促进了纤维细胞复苏,并在老年小鼠中增强了原蛋白合成.
结论:
- 在MN@EV/SC贴片提供了一个舒适和有效的平台,通过皮肤输送EV.
- 这项技术通过调节皮肤微环境,显示出皮肤再生的潜力.
- 集成吸管设计增强了MN粘附力和EV透深度.
相关概念视频
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...